Probiotics and Postbiotics as NHPs in Canada: Strain Identity, Viable Counts and Claims

Probiotics are one of the fastest growing categories on the Canadian supplement shelf, and also one of the most misunderstood from a regulatory point of view. A live bacterial culture is not an ordinary ingredient. It is a living organism that must be identified down to the strain, counted while it is still alive, and kept alive on the shelf until the day a consumer takes it. Health Canada regulates these products as Natural Health Products, and that classification carries expectations a food grade quality system will not meet.

Postbiotics and synbiotics make the picture harder again. The moment a culture is heat killed or inactivated, it falls outside the Health Canada Probiotics monograph, and the compliance route changes. This guide explains how Health Canada classifies probiotics, postbiotics and synbiotics, what the Natural and Non-prescription Health Products Directorate expects for strain identity, viable counts and stability, and which claims you can and cannot make. It is written for founders, regulatory affairs managers and quality leads bringing a live culture product to the Canadian market.

Executive Summary

In Canada, a probiotic sold as a capsule, tablet or measured liquid is a Natural Health Product. It needs a product licence and a Natural Product Number before it can be sold, and every live organism in the formula must be identified to the strain level, counted in colony forming units, and shown to survive to the end of shelf life. Health Canada's Probiotics monograph sets out permitted species, a minimum daily dose, acceptable claims and stability expectations. The key points below frame the rest of this guide.

Classification: live probiotics in pharmaceutical dosage forms are Natural Health Products under the Natural Health Products Regulations, not foods.
Identity: genus and species are not enough. The monograph requires strain characterization, a strain designation, and a full assessment of virulence properties.
Potency: live organisms are declared in colony forming units per dosage unit, with a general minimum daily dose of 1.0 x 10 to the 7 CFU.
Stability: at least 80 percent of the labelled count must remain viable at the end of shelf life, supported by real time data.
Postbiotics: non viable, heat killed and inactivated preparations are excluded from the Probiotics monograph and need their own classification and evidence.

How Does Health Canada Classify Probiotics?

In short: Health Canada regulates probiotics as Natural Health Products under the Natural Health Products Regulations (SOR/2003-196). To be sold legally, a probiotic in a pharmaceutical dosage form needs a product licence and a Natural Product Number, and the live organisms must be identified to the strain and quantified in colony forming units. A food grade specification alone will not satisfy the file.

The Natural and Non-prescription Health Products Directorate, or NNHPD, assesses natural health products before they reach the market. For probiotics it maintains a Probiotics monograph inside the Natural Health Products Ingredients Database. The monograph lists the bacteria and yeasts Health Canada accepts as probiotic medicinal ingredients, along with the doses, claims and specifications that go with them. Referencing the monograph is the fastest route to a licence, because the applicant attests that the product complies with the recommended conditions of use rather than submitting a full evidence package.

There is an important scope limit. The Probiotics monograph covers natural health products in pharmaceutical dosage forms, such as capsules, tablets, powders and liquids measured in teaspoons or tablespoons. It does not cover probiotics delivered in a food format, such as yogurt, kefir or a fortified beverage. Foods are regulated separately, and only a short list of general claims about the nature of gut flora is accepted on a food label. If your product is a capsule, you are almost certainly in Natural Health Product territory, and you should confirm the boundary early using Health Canada's classification framework.

Two routes exist to a product licence. A compendial application references the monograph and stays within its permitted species, doses and claims. A non-monograph application is used when a strain, dose or claim sits outside the monograph, and it must be supported by the applicant's own evidence of safety and efficacy under the recommended conditions of use. Choosing the wrong route at the outset is a common cause of delay.

Probiotic, Postbiotic or Synbiotic? The Definitions That Decide Your Pathway

In short: A probiotic is a live microorganism that confers a benefit. A postbiotic is a preparation of inactivated microorganisms or their components. A synbiotic combines live organisms with a substrate they use. Only live probiotics fit the Probiotics monograph. Postbiotics and synbiotics need a tailored classification and evidence strategy, because a non viable ingredient does not qualify as a probiotic.

These definitions come from the FAO and WHO work on probiotics and from the consensus statements of the International Scientific Association for Probiotics and Prebiotics. Health Canada's monograph aligns with them in one decisive way: it turns on whether the organism is alive. The table below shows how the four related categories are typically handled in Canada.

Category	What it is	Live organisms?	Typical Canadian pathway
Probiotic	Live microorganisms that, in adequate amounts, confer a health benefit	Yes	Natural Health Product; Probiotics monograph or own evidence; NPN required
Prebiotic	A substrate selectively used by host microorganisms, often a fibre	No	NHP (a Prebiotics monograph was published in 2026) or food, depending on form and claim
Synbiotic	A combination of live microorganisms plus a substrate they use	Partly	NHP; evidence needed for both the live and the substrate component
Postbiotic	A preparation of inactivated microorganisms or their components that confers a benefit	No	Outside the Probiotics monograph; case by case NHP classification and evidence

The monograph is explicit on this point. Any non viable form of the listed medicinal ingredients, for example heat killed or thermostabilised cultures, is excluded from the monograph and from the compendial application process. That single sentence is why a postbiotic cannot simply borrow a probiotic file. If your product is built on inactivated cells or cell fragments, you are outside the monograph and you need a classification decision and an evidence strategy of your own before you build the submission.

Strain Identity: Why Genus and Species Are Not Enough

In short: Health Canada wants strain level identity, not just genus and species. The monograph requires species identification, strain characterization, a strain designation on the file, and a complete assessment of virulence properties, including the antibiotic resistance profile, virulence factor production and toxigenic activity. A label that reads only Lactobacillus acidophilus, with no strain, cannot be matched to the safety evidence.

Probiotic benefits are strain specific. Two strains of the same species can behave very differently in the gut, so Health Canada treats the strain, not the species, as the unit of evidence. When you attest to the Probiotics monograph, you are confirming that the product provides species identification, strain characterization, quantification in colony forming units, and a complete assessment of virulence properties. That virulence assessment is not a formality. It covers the antibiotic resistance profile, the production of virulence factors, and toxigenic activity, and it must be established for each live microorganism in the formula.

A practical trap sits in the nomenclature. In 2020 the genus Lactobacillus was split into more than twenty genera, so a strain once called Lactobacillus casei is now Lacticaseibacillus casei, and Lactobacillus rhamnosus is now Lacticaseibacillus rhamnosus. Health Canada's monograph carries the current names alongside the former names. Files, specifications and labels that still use only the old genus create avoidable questions during review and confusion at inspection. Use the current binomial, record the strain designation, and keep the strain deposit or collection number in the file so the organism can be traced to its safety data.

A common inspection and review finding is an identity gap: a finished product specification that names the species but not the strain, or a certificate of analysis from a culture supplier that cannot be reconciled to the strain named in the licence. If the strain on the shelf cannot be tied to the strain in the evidence, the product's safety and efficacy case falls apart. This is exactly the kind of documentation discipline a gap assessment is designed to catch before Health Canada does.

Viable Counts: Counting Something That Is Alive

In short: Probiotic potency is declared in colony forming units per dosage unit, not in milligrams. The Probiotics monograph sets a general minimum daily dose of 1.0 x 10 to the 7 colony forming units, whether from a single strain or a combination. Each strain's count must be consistent across the product licence application, the label and the finished product specifications.

Because a probiotic is alive, its strength is measured by how many organisms can still form colonies, expressed in colony forming units, or CFU. The monograph requires that all individual strain quantities of live microorganisms be indicated in CFU per dosage unit on the application form, the label and the finished product specifications. A count in milligrams, or a vague total that does not break down by strain, will not meet the requirement. The minimum daily dose for general uses is 1.0 x 10 to the 7 CFU per day, counted as the total across all live organisms in the formula, as either a single ingredient or a combination.

Requirement	What Health Canada expects
Unit of measure	Colony forming units (CFU) per dosage unit, not milligrams or weight
Minimum daily dose	1.0 x 10 to the 7 CFU per day for general uses, as a single strain or in combination
Consistency	Each strain's CFU count matches across the licence application, label and specifications
End of shelf life	At least 80 percent of the labelled count still viable at expiry
Cryoprotectants	Ingredients added to preserve viability disclosed as non-medicinal ingredients

The count on the label is a promise that must hold to the end of shelf life, which is why responsible manufacturers formulate with a deliberate overage. The organism population declines over time, so you fill to a higher count at release to ensure the labelled number is still present at expiry. Setting that overage is a data exercise, not a guess, and it depends directly on the stability programme described in the next section.

Stability: Dating a Product That Is Alive

In short: A probiotic's shelf life is the date to which the labelled viable count still holds. The monograph expects stability and viability measures that keep at least 80 percent of the labelled count present at the end of shelf life, supported by real time data generated under the NNHPD Quality of Natural Health Products Guide. Storage conditions on the label must be justified by that data.

For most products, expiry dating protects against chemical degradation. For a probiotic, the thing that decays is the population of living organisms. Set the date too far out and the product will not deliver its labelled count by the time a consumer opens it. The monograph is specific: the stability and viability measures put in place must ensure that a minimum of 80 percent of the quantity declared on the label is present at the end of shelf life. That number should be demonstrated with real time stability data on the finished product in its market packaging, in line with the requirements of the Quality of Natural Health Products Guide.

Two practical points follow. First, storage conditions are part of the claim. If the product is labelled shelf stable at room temperature, the stability data must support room temperature storage; if it needs refrigeration, the label and the data must agree. Second, cryoprotectants and other ingredients added during manufacturing to preserve viability must be declared as non-medicinal ingredients. A frequent gap for importers is relying on a supplier certificate that reports the count only at release, with no end of shelf life data and no study in the actual finished package. The expiry dating discipline is the same one set out in our guide to NHP stability programmes under GUI-0158 version 4.0, which walks through protocol, report and expiry dating for natural health products.

Claims: What You Can Say, and What You Cannot

In short: The Probiotics monograph permits a defined set of claims, including source of probiotics, helps support intestinal and gastrointestinal health, and could promote a favourable gut flora. Anything beyond the monograph, especially a strain specific benefit, needs strain specific human evidence. A claim to treat or prevent a disease pushes the product toward drug regulation and needs a very different evidence base.

Health Canada accepts a limited menu of claims for products that reference the Probiotics monograph. General statements such as source of probiotics, helps support intestinal or gastrointestinal health, and could promote a favourable gut flora are available where the product meets the minimum daily dose and the other monograph conditions. These are non strain specific claims about the general role of probiotics.

The moment you want to say more, the evidence bar rises. A strain specific benefit, for example a claim that a named strain reduces a particular symptom, must be supported by strain specific human evidence and is handled as a non-monograph submission. A claim to diagnose, treat, cure or prevent a disease is a drug claim, and making it on a natural health product is both a licensing problem and a compliance risk. Postbiotics deserve a special warning here: because they are not live probiotics, they cannot borrow probiotic claims, and any benefit statement has to stand on its own evidence for that specific inactivated preparation.

GMP and Site Licensing for Live Culture Products

In short: Manufacturing, packaging, labelling or importing a probiotic natural health product in Canada requires a site licence and compliance with Good Manufacturing Practices for natural health products under GUI-0158. Live organisms add controls a conventional file does not need, from strain segregation to the challenge of testing microbial purity when the medicinal ingredient is itself a living microorganism.

A product licence lets you sell the product. A site licence lets you make, package, label or import it, and it is contingent on Good Manufacturing Practices. Health Canada reset those expectations with version 4.0 of the GMP guide, GUI-0158, which is now in force. Our overview of the 2026 NHP GMP reset under GUI-0158 explains how the end of foreign site reference numbers and the strengthened evidence expectations change site licence compliance, and it is essential reading before you file.

Live cultures create GMP problems that ordinary ingredients do not. Different strains have to be segregated to prevent cross contamination, because a stray organism from one production line can invalidate the identity and count of another product. Microbial purity testing is genuinely awkward when the medicinal ingredient is a living microorganism, so the monograph requires a documented rationale explaining how the finished product complies, including how the intended live organism is distinguished from a contaminant and how quality assurance measures ensure microbial purity. These are the details a mock inspection or a supplier audit should probe before Health Canada arrives.

Probiotic and Postbiotic Compliance Checklist

Use the checklist below to pressure test a live culture file before you submit or before an inspection. It mirrors the free downloadable worksheet at the end of this article.

Confirm classification: is the product a live probiotic (monograph may apply) or a non viable postbiotic (monograph does not apply)?
Confirm the dosage form is a natural health product format (capsule, tablet, powder, measured liquid), not a food.
Record each organism to the strain level using current nomenclature, with a strain designation or deposit number.
Hold a complete virulence assessment for each strain: antibiotic resistance profile, virulence factor production and toxigenic activity.
Declare each strain's potency in colony forming units per dosage unit on the application, label and finished product specifications, consistently.
Meet the minimum daily dose of 1.0 x 10 to the 7 CFU per day for general uses, single or combined.
Hold real time stability data showing at least 80 percent of the labelled count viable at end of shelf life, in the market package.
Match label storage conditions to the stability data, and disclose cryoprotectants as non-medicinal ingredients.
Limit claims to those the licence supports, and never let marketing copy exceed the licensed claims.
Hold a site licence and GMP evidence under GUI-0158, including strain segregation and a microbial purity rationale.

Common Mistakes

The same avoidable errors surface again and again in probiotic files and inspections. Watching for them shortens review times and reduces compliance risk.

Species without strain. Naming Lactobacillus acidophilus with no strain designation, so the organism cannot be tied to its safety evidence.
Milligrams instead of CFU. Declaring potency by weight rather than colony forming units per dosage unit.
Release counts posing as shelf life data. Relying on a supplier count at manufacture, with no end of shelf life viability study in the finished package.
Treating a postbiotic as a probiotic. Using the Probiotics monograph for a heat killed or inactivated preparation that the monograph explicitly excludes.
Outdated nomenclature. Labels and files that still use only the pre 2020 Lactobacillus names, creating review questions.
Claims beyond the licence. Marketing strain specific or disease related benefits the product licence does not support.
No microbial purity rationale. Failing to document how purity is assured when the medicinal ingredient is itself a live organism.

Frequently Asked Questions

Are probiotics regulated in Canada?

Yes. Probiotics sold in pharmaceutical dosage forms such as capsules, tablets, powders and measured liquids are regulated as Natural Health Products under the Natural Health Products Regulations. They require a product licence and a Natural Product Number before sale, and Health Canada assesses safety, quality and efficacy before the product reaches the market. Probiotics delivered in a food format, such as yogurt, are regulated as foods instead.

Do probiotics need an NPN?

A probiotic natural health product must display a Natural Product Number, or NPN, on its label, which shows Health Canada has assessed and licensed the product. To obtain one you submit a product licence application, either referencing the Probiotics monograph for permitted species, doses and claims, or supporting your own strain, dose or claim with evidence in a non-monograph application.

What is the minimum probiotic dose Health Canada accepts?

For general uses, the Probiotics monograph sets a minimum daily dose of 1.0 x 10 to the 7 colony forming units per day. That total can come from a single strain or from a combination of strains, but it must be declared in colony forming units per dosage unit and be consistent across the licence application, the label and the finished product specifications.

How do you set a shelf life for a live culture supplement?

You generate real time stability data on the finished product in its market packaging and set the expiry date to the point at which at least 80 percent of the labelled viable count still remains. Because the organisms decline over time, manufacturers formulate with an overage so the labelled count is met at the end of shelf life, and the labelled storage conditions must match the stability data.

How are postbiotics regulated in Canada?

Postbiotics are preparations of inactivated microorganisms or their components, so they are not live probiotics. The Probiotics monograph specifically excludes non viable forms such as heat killed or thermostabilised cultures. As a result, a postbiotic needs its own classification decision and its own evidence of safety and efficacy, and it cannot rely on the claims or the compendial route available to live probiotics.

Is a synbiotic treated differently from a probiotic?

A synbiotic combines live microorganisms with a substrate that those organisms use, so it has both a probiotic component and a prebiotic component. In practice this means the file must support both parts: the live organisms against the probiotic expectations for identity, count and stability, and the substrate against the relevant prebiotic evidence. Health Canada published a prebiotics monograph in 2026, which is a useful reference point for the substrate side.

How MFLRC Can Help

Live culture products reward companies that get the regulatory groundwork right and punish those that improvise. MF License and Regulatory Consultants helps probiotic, postbiotic and synbiotic companies move from concept to a defensible Canadian file. We scope the classification decision, map the monograph or non-monograph route, and build the product licence application, drawing on the same discipline set out in our guide to NHP compliance in Canada. Our regulatory affairs, licensing and import and export team handles the submission, while our quality control services team builds the stability programme, specifications and GMP evidence a site licence needs under GUI-0158.

We also run gap assessments and mock inspections that catch the identity, count and claims problems described above before Health Canada does, and we align marketing claims to the licence so advertising does not create compliance risk. Whether you are filing your first probiotic NPN or cleaning up a portfolio, we can help you scope the work. If you are weighing whether your product is even a natural health product, our overview of the difference between an NHP licence and a cannabis licence is a useful starting point, and a short consultation will tell you where you stand.

Book a Consultation

Conclusion

Probiotics are regulated as Natural Health Products in Canada, and the rules follow from a simple fact: the ingredient is alive. That is why Health Canada asks for strain level identity, a virulence assessment, potency in colony forming units, a minimum daily dose, and stability data proving the labelled count survives to the end of shelf life. Postbiotics and synbiotics sit outside the neat monograph path and need their own classification and evidence. Companies that treat these requirements as design inputs, rather than paperwork to be rushed at the end, reach the market faster and stay there. Build the identity, count, stability and claims discipline in from the start, and a live culture product becomes a durable asset rather than a compliance liability.